NHLBI ASTHMA NETWORKS: IMPROVING PATIENT CARE, MOVING TOWARD PERSONALIZED MEDICINE

Overview

Journal Trans Am Clin Climatol Assoc

Specialty Rehabilitation Medicine

Date 2022 Oct 5

PMID 36196171

Authors

Stephen P Peters

Affiliations

Soon will be listed here.

Abstract

The first NHLBI Clinical Trials Research Network was the Asthma Clinical Research Network (ACRN 1), which was born in 1993 to perform multiple controlled clinical trials for asthma: "… dispassionately examine new & existing therapies for asthma" and "… rapidly communicate findings to medical community," and therefore, to perform clinical trials drug companies could not or would not do. Among the many areas studied by the ACRN and its successor networks, through 2019, was how to effectively and safely use long-acting beta-agonists and to find novel alternatives for them. In its Tiotropium Add-On Trial (TALC) trial, the ACRN demonstrated that tiotropium as add on-therapy to inhaled corticosteroids (ICS) was effective and non-inferior to long-acting beta-agonist add on-therapy. During the lifetime of the clinical trial networks (1993-2020), 71 manuscripts including 25 major clinical trials were published, many which have laid the groundwork for precision approaches for asthma therapy and the now ongoing PrecISE Asthma Network.

References

Peters S, Kunselman S, Icitovic N, Moore W, Pascual R, Ameredes B . Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med. 2010; 363(18):1715-26. PMC: 3011177. DOI: 10.1056/NEJMoa1008770. View

Castro M, King T, Kunselman S, Cabana M, Denlinger L, Holguin F . Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA. 2014; 311(20):2083-91. PMC: 4217655. DOI: 10.1001/jama.2014.5052. View

Wechsler M, Szefler S, Ortega V, Pongracic J, Chinchilli V, Lima J . Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. N Engl J Med. 2019; 381(13):1227-1239. PMC: 7026584. DOI: 10.1056/NEJMoa1905560. View

Guilbert T, Morgan W, Krawiec M, Lemanske Jr R, Sorkness C, Szefler S . The Prevention of Early Asthma in Kids study: design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin Trials. 2004; 25(3):286-310. DOI: 10.1016/j.cct.2004.03.002. View

Drazen J, Israel E, Boushey H, Chinchilli V, Fahy J, FISH J . Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med. 1996; 335(12):841-7. DOI: 10.1056/NEJM199609193351202. View

Szefler S, Martin R, King T, Boushey H, Cherniack R, Chinchilli V . Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002; 109(3):410-8. DOI: 10.1067/mai.2002.122635. View

Weinmann G, Croxton T, Aggarwal N, Twery M, Kiley J . A Perspective: Division of Lung Diseases at Fifty. Am J Respir Crit Care Med. 2019; 200(12):1466-1471. PMC: 6909826. DOI: 10.1164/rccm.201910-1999PP. View

Boushey H, Sorkness C, King T, Sullivan S, Fahy J, Lazarus S . Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005; 352(15):1519-28. DOI: 10.1056/NEJMoa042552. View

Martin R, Szefler S, King T, Kraft M, Boushey H, Chinchilli V . The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol. 2007; 119(1):73-80. PMC: 2872157. DOI: 10.1016/j.jaci.2006.10.035. View

10.

Nelson H, Weiss S, Bleecker E, Yancey S, Dorinsky P . The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006; 129(1):15-26. DOI: 10.1378/chest.129.1.15. View

11.

Georas S, Wright R, Ivanova A, Israel E, LaVange L, Akuthota P . The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. J Allergy Clin Immunol. 2021; 149(2):488-516.e9. PMC: 8821377. DOI: 10.1016/j.jaci.2021.10.035. View

12.

Donohue J . Safety and efficacy of beta agonists. Respir Care. 2008; 53(5):618-22. View

13.

Kerstjens H, Engel M, Dahl R, Paggiaro P, Beck E, Vandewalker M . Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012; 367(13):1198-207. DOI: 10.1056/NEJMoa1208606. View

14.

Smith L . Anticholinergics for patients with asthma?. N Engl J Med. 2010; 363(18):1764-5. DOI: 10.1056/NEJMe1009429. View

15.

Taylor D, Sears M, Cockcroft D . The beta-agonist controversy. Med Clin North Am. 1996; 80(4):719-48. DOI: 10.1016/s0025-7125(05)70465-x. View

16.

Calhoun W, Ameredes B, King T, Icitovic N, Bleecker E, Castro M . Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA. 2012; 308(10):987-97. PMC: 3697088. DOI: 10.1001/2012.jama.10893. View

17.

Lemanske Jr R, Sorkness C, Mauger E, Lazarus S, Boushey H, Fahy J . Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA. 2001; 285(20):2594-603. DOI: 10.1001/jama.285.20.2594. View

18.

Wechsler M, Kunselman S, Chinchilli V, Bleecker E, Boushey H, Calhoun W . Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet. 2009; 374(9703):1754-64. PMC: 2914569. DOI: 10.1016/S0140-6736(09)61492-6. View

19.

Bateman E, Kornmann O, Schmidt P, Pivovarova A, Engel M, Fabbri L . Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol. 2011; 128(2):315-22. DOI: 10.1016/j.jaci.2011.06.004. View

20.

Sutherland E, Busse W . Designing clinical trials to address the needs of childhood and adult asthma: the National Heart, Lung, and Blood Institute's AsthmaNet. J Allergy Clin Immunol. 2013; 133(1):34-8.e1. PMC: 3909925. DOI: 10.1016/j.jaci.2013.10.025. View